National Medical Care Company (TADAWUL:4005)
Saudi Arabia · Delayed Price · Currency is SAR 122.00
-0.30 (-0.25%)
Aug 13, 2026, 3:19 PM AST
TADAWUL:4005 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,662 | 1,600 | 1,294 | 1,082 | 917.93 | 845.38 | |
Revenue Growth | 12.15% | 23.71% | 19.59% | 17.85% | 8.58% | 4.50% |
Cost of Revenue | 1,077 | 1,017 | 847.98 | 714.93 | 630.99 | 601.08 |
Gross Profit | 584.16 | 582.88 | 445.7 | 366.85 | 286.95 | 244.3 |
Selling, General & Admin | 225.27 | 211.97 | 168.23 | 124.53 | 93.08 | 79.09 |
Other Operating Expenses | -1.61 | -1.4 | -6.33 | -4.03 | -8.35 | -8.19 |
Operating Expenses | 242.06 | 228.34 | 194.62 | 120.13 | 89.68 | 79.9 |
Operating Income | 342.1 | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 |
Interest Expense | -28.61 | -26.97 | -22.74 | -3.5 | - | - |
Interest & Investment Income | 14.21 | 18.8 | 19.48 | 21.37 | 1.24 | - |
EBT Excluding Unusual Items | 327.7 | 346.36 | 247.83 | 264.59 | 198.5 | 164.4 |
Legal Settlements | - | - | 42.34 | - | - | - |
Pretax Income | 327.7 | 346.36 | 290.16 | 264.59 | 198.5 | 164.4 |
Income Tax Expense | 28.11 | 27.89 | -4.54 | 23.67 | 28.43 | 28.04 |
Net Income | 299.59 | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 |
Net Income to Common | 299.59 | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 |
Net Income Growth | -3.11% | 8.07% | 22.32% | 41.66% | 24.73% | 40.18% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Change | -0.03% | -0.17% | -0.18% | - | - | - |
EPS (Basic) | 6.70 | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 |
EPS (Diluted) | 6.70 | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 |
EPS Growth | -3.08% | 8.25% | 22.54% | 41.66% | 24.73% | 40.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -283.57 | 26.8 | 136.63 | 412.73 | 185.83 | 61.61 |
Free Cash Flow Per Share | -6.34 | 0.60 | 3.05 | 9.20 | 4.14 | 1.37 |
Dividend Per Share | 3.000 | 3.000 | 2.000 | 2.000 | 1.000 | 1.000 |
Dividend Growth | 50.00% | 50.00% | 0% | 100.00% | 0% | 0% |
Gross Margin | 35.16% | 36.42% | 34.45% | 33.91% | 31.26% | 28.90% |
Operating Margin | 20.59% | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% |
Profit Margin | 18.03% | 19.90% | 22.78% | 22.27% | 18.53% | 16.13% |
Free Cash Flow Margin | -17.07% | 1.68% | 10.56% | 38.15% | 20.24% | 7.29% |
EBITDA | 423.21 | 437.75 | 315.14 | 290.94 | 239.17 | 214.56 |
EBITDA Margin | 25.47% | 27.35% | 24.36% | 26.90% | 26.05% | 25.38% |
D&A For EBITDA | 81.11 | 83.21 | 64.06 | 44.22 | 41.9 | 50.16 |
EBIT | 342.1 | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 |
EBIT Margin | 20.59% | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% |
Effective Tax Rate | 8.58% | 8.05% | - | 8.95% | 14.32% | 17.06% |